Skip to main content

Table 1 Functional changes of Vγ9/Vδ 2 T lymphocytes in BD patients and controls

From: Phenotype and functional changes of Vγ9/Vδ2 T lymphocytes in Behçet's disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation and cytotoxicity

 

Active BD

Inactive BD

Controls

P

EF of Vγ9/Vδ2

295 ± 44

36 ± 8

30 ± 8

< 0.0001

Vγ9/Vδ 2 TNF-RII

10,422 ± 1,694

4,087 ± 1.671

4,512 ± 1436

< 0.0001

IFN-γ (% of Vγ9/Vδ 2)

40.4 ± 8.2

18 ± 7

11 ± 4

< 0.001

Perforin (mOD units)

27,581 ± 4.611

5,247 ± 1,230

4,980 ± 1,110

< 0.001

Granzyme A (mOD units)

818 ± 97

589 ± 21

550 ± 30

< 0.05

  1. BD: Behçet's disease; EF: Expansion factor.